Ito Masahiro, Iwatani Misa, Kamada Yusuke, Sogabe Satoshi, Nakao Shoichi, Tanaka Toshio, Kawamoto Tomohiro, Aparicio Samuel, Nakanishi Atsushi, Imaeda Yasuhiro
Pharmaceutical Research Division, Takeda Pharmaceutical Company Limited, 26-1, Muraoka-Higashi 2-chome, Fujisawa, Kanagawa 251-8555, Japan.
Pharmaceutical Research Division, Takeda Pharmaceutical Company Limited, 26-1, Muraoka-Higashi 2-chome, Fujisawa, Kanagawa 251-8555, Japan.
Bioorg Med Chem. 2017 Apr 1;25(7):2200-2209. doi: 10.1016/j.bmc.2017.02.035. Epub 2017 Feb 20.
Eukaryotic initiation factor 4A3 (eIF4A3), an ATP-dependent RNA helicase, is a core component of exon junction complex (EJC). EJC has a variety of roles in RNA metabolism such as translation, surveillance, and localization of spliced RNA. It is worthwhile to identify selective eIF4A3 inhibitors with a view to investigating the functions of eIF4A3 and EJC further to clarify the roles of the ATPase and helicase activities in cells. Our chemical optimization of hit compound 2 culminated in the discovery of ATP-competitive eIF4A3 inhibitor 18 with submicromolar ATPase inhibitory activity and excellent selectivity over other helicases. Hence, compound 18 could be a valuable chemical probe to elucidate the detailed functions of eIF4A3 and EJC.
真核生物起始因子4A3(eIF4A3)是一种依赖ATP的RNA解旋酶,是外显子连接复合体(EJC)的核心成分。EJC在RNA代谢中具有多种作用,如翻译、监测和剪接RNA的定位。为了进一步研究eIF4A3和EJC的功能,以阐明ATP酶和解旋酶活性在细胞中的作用,鉴定选择性eIF4A3抑制剂是很有必要的。我们对命中化合物2进行化学优化,最终发现了ATP竞争性eIF4A3抑制剂18,其具有亚微摩尔ATP酶抑制活性,对其他解旋酶具有优异的选择性。因此,化合物18可能是阐明eIF4A3和EJC详细功能的有价值的化学探针。